fda warning letters glp-1 compounders september 2025 takes aim at telehealth companies for promoting unofficial weight loss drug dupes FDA Targets GLP-1 and Peptide
Description
Slowed gastric emptying: One of the critical mechanisms of GLP-1 injections is their ability to slow down the emptying of the stomach
Lv YQ, Yuan L, Sun Y, Dou HW, Su JH, Hou ZP, et al
Patients with gastroparesis face particular challenges since semaglutide further slows already-delayed gastric emptying
doi: 10.3389/fcimb.2023.1142041 67 GuYZhouGZhouFLiYWuQHeHet al
Other loci, such as glucokinase regulator (GCKR) and membrane bound O-acyltransferase domain-containing 7 (MBOAT7), influence glucose metabolism, phospholipid remodeling, and insulin sensitivity, highlighting the tight link between metabolic dysfunction and liver injury
